Cite
HARVARD Citation
Ugradar, S. et al. (2022). A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface. Journal of neuro-ophthalmology. 42 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ugradar, S. et al. (2022). A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface. Journal of neuro-ophthalmology. 42 (1), p. . [Online].